{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:45:41Z","timestamp":1790707541530,"version":"4.1.0"},"reference-count":74,"publisher":"Radiation Research Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1667\/rr3558.1","type":"journal-article","created":{"date-parts":[[2006,7,17]],"date-time":"2006-07-17T17:08:12Z","timestamp":1153156092000},"page":"128-140","source":"Crossref","is-referenced-by-count":21,"title":["Normal Organ Radiation Dosimetry and Associated Uncertainties in Nuclear Medicine, with Emphasis on Iodine-131"],"prefix":"10.1667","volume":"166","author":[{"given":"A. B.","family":"Brill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bouville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"i0033-7587-166-1-128-b14","doi-asserted-by":"crossref","unstructured":"Hui, T. E., D. R. Fisher, O. W. Press, J. F. Eary, J. N. Weinstein, C. C. Badger, and I. D. Bernstein. Localized beta dosimetry of131I-labeled antibodies in follicular lymphoma. Med. Phys 19:97\u2013104.1992.","DOI":"10.1118\/1.596932"},{"key":"i0033-7587-166-1-128-b15","doi-asserted-by":"crossref","unstructured":"Reddy, A. R. and A. Kaul. Microscopic dose distributions due to iodine isotopes in thyroid. Radiat. Environ. Biophys 5:229\u2013239.(1978.","DOI":"10.1007\/BF02176792"},{"key":"i0033-7587-166-1-128-b16","unstructured":"Siegel, J. A. and M. G. Stabin. Absorbed fractions for electrons and beta particles in spheres of various sizes. J. Nucl. Med 35:152\u2013156.1994."},{"key":"i0033-7587-166-1-128-b17","doi-asserted-by":"crossref","unstructured":"Fritsch, P., C. Champion, F. Menetrier, and J. Delforge. Uncertainties on the committed equivalent dose to the thyroid as a function of age for different iodine isotopes. Radiat. Prot. Dosim 105:247\u2013250.2003.","DOI":"10.1093\/oxfordjournals.rpd.a006233"},{"key":"i0033-7587-166-1-128-b18","unstructured":"Malone, J. F. The radiation biology of the thyroid. Curr. Top. Radiat. Res. Q 10:263\u2013368.1975."},{"key":"i0033-7587-166-1-128-b19","doi-asserted-by":"publisher","DOI":"10.2307\/3576007"},{"key":"i0033-7587-166-1-128-b22","unstructured":"Stabin, M. G., J. Siegel, J. Hunt, R. Sparks, J. Lipsztein, and K. F. Eckerman. RADAR\u2014The radiation dose assessment resource. An online source of dose information for nuclear medicine and occupational radiation safety. J. Nucl. Med 42:243. 2001."},{"key":"i0033-7587-166-1-128-b26","unstructured":"Stabin, M. G. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med 37:538\u2013546.(1996."},{"key":"i0033-7587-166-1-128-b30","unstructured":"Stabin, M. G., R. B. Sparks, and E. Crowe. OLINDA\/EXM\u2014the second-generation personal computer software for internal dose assessment in nuclear medicine. J. Nucl. Med 46:1023\u20131027.2005."},{"key":"i0033-7587-166-1-128-b31","doi-asserted-by":"crossref","unstructured":"Petoussi-Henss, N., M. Zankl, U. Fill, and D. Regulla. The GSF family of voxel phantoms. Phys. Med. Biol 47:89\u2013106.2002.","DOI":"10.1088\/0031-9155\/47\/1\/307"},{"key":"i0033-7587-166-1-128-b32","unstructured":"Sgouros, G., S. Chiu, K. S. Pentlow, L. J. Brester, H. Kalaigian, B. Baldwin, F. Daghighian, M. C. Graham, S. M. Larson, and R. Mohan. Three-dimensional dosimetry for radioimmunotherapy treatment planning. J. Nucl. Med 34:1595\u20131601.1993."},{"key":"i0033-7587-166-1-128-b36","unstructured":"Dewaraja, Y. K., S. J. Wilderman, M. Ljungberg, K. F. Koral, K. Zasadny, and M. S. Kaminiski. Accurate dosimetry in131I radionuclide therapy using patient-specific 3 dimensional methods for SPECT reconstruction and absorbed dose calculation. J. Nucl. Med 46:840\u2013849.2005."},{"key":"i0033-7587-166-1-128-b38","doi-asserted-by":"crossref","unstructured":"Fleury, Y., G. Van Melle, V. Woringer, R. C. Gaillard, and L. Portmann. Sex-dependent variations and timing of thyroid growth during puberty. J. Clin. Endocrinol. Metab 86:750\u2013754.2001.","DOI":"10.1210\/jc.86.2.750"},{"key":"i0033-7587-166-1-128-b39","doi-asserted-by":"crossref","unstructured":"Zanzonico, P. B. and D. V. Becker. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by131I from radioactive fallout. Health Phys 78:660\u2013667.2000.","DOI":"10.1097\/00004032-200006000-00008"},{"key":"i0033-7587-166-1-128-b44","doi-asserted-by":"publisher","DOI":"10.1097\/00004032-200206000-00007"},{"key":"i0033-7587-166-1-128-b46","doi-asserted-by":"crossref","unstructured":"Van Middlesworth, L. Radioactive iodide uptake of normal newborn infants. AMA J. Dis. Child 88:439\u2013442.1954.","DOI":"10.1001\/archpedi.1954.02050100441002"},{"key":"i0033-7587-166-1-128-b47","doi-asserted-by":"crossref","unstructured":"Johansson, L., S. Leide-Sveggorn, S. Mattson, and B. Nosslin. Biokinetics of iodide in man: Refinements of current ICRP dosimetry models. Cancer Biother. Radiopharm 18:445\u2013450.2003.","DOI":"10.1089\/108497803322285206"},{"key":"i0033-7587-166-1-128-b48","doi-asserted-by":"crossref","unstructured":"Edmonds, C. J. and T. Smith. The long term hazards of the treatment of thyroid cancer with radioiodine. Br. J. Cancer 59:45\u201351.1986.","DOI":"10.1259\/0007-1285-59-697-45"},{"key":"i0033-7587-166-1-128-b49","doi-asserted-by":"crossref","unstructured":"Jonsson, H. and S. Mattson. Excess radiation absorbed doses from non-optimized radioiodine treatment of hyperthyroidism. Radiat. Prot. Dosim 108:107\u2013114.2004.","DOI":"10.1093\/rpd\/nch013"},{"key":"i0033-7587-166-1-128-b50","unstructured":"Zanzonico, P. B., D. V. Becker, and J. R. Hurley. Enhancement of radioiodine treatment of \u201csmall pool\u201d hyperthyroidism using antithyroid drugs: Kinetics and dosimetry. J. Nucl. Med 45:202\u2013208.(2004."},{"key":"i0033-7587-166-1-128-b51","unstructured":"Hay, I. D., W. M. McConahey, and J. R. Goellner. Managing patients with papillary thyroid carcinoma: Insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans. Am. Clin. Climatol. Assoc 113:241\u2013260.2002."},{"key":"i0033-7587-166-1-128-b52","unstructured":"Sisson, J. C., B. L. Shulkin, and S. Lawson. Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of131I. J. Nucl. Med 44:898\u2013903.2003."},{"key":"i0033-7587-166-1-128-b53","unstructured":"Maxon, H. R. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q. J. Nucl. Med 43:313\u2013323.1999."},{"key":"i0033-7587-166-1-128-b54","unstructured":"Lassmann, M., M. Luster, H. Hanscheid, and C. Reiners. Impact of131I diagnostic activities on the biokinetics of thyroid remnants. J. Nucl. Med 45:619\u2013625.2004."},{"key":"i0033-7587-166-1-128-b55","unstructured":"Robbins, R. R. and M. J. Schlumberger. The evolving role of131I for the treatment of differentiated thyroid cancer. J. Nucl. Med 46:Suppl. 28S\u201337S.2005."},{"key":"i0033-7587-166-1-128-b56","doi-asserted-by":"crossref","unstructured":"Luster, M., F. Lippi, B. Jarzab, P. Perros, M. Lassmann, C. Reiners, and F. Pacini. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: A comprehensive review. Endocr. Relat. Cancer 12:49\u201364.2005.","DOI":"10.1677\/erc.1.00830"},{"key":"i0033-7587-166-1-128-b57","doi-asserted-by":"crossref","unstructured":"Koong, S. S., J. C. Reynolds, E. G. Movius, A. M. Keenan, K. B. Ain, M. C. Lakshmanan, and J. Robbins. Lithium as a potential adjuvant to131I therapy of metastatic, well differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab 84:912\u2013916.1999.","DOI":"10.1210\/jcem.84.3.5527"},{"key":"i0033-7587-166-1-128-b58","doi-asserted-by":"crossref","unstructured":"Larson, S. M. and R. Robbins. Positron emission tomography in thyroid cancer management. Semin. Roentgenol 37:169\u2013174.(2002.","DOI":"10.1016\/S0037-198X(02)80035-9"},{"key":"i0033-7587-166-1-128-b59","doi-asserted-by":"publisher","DOI":"10.1097\/00004032-200405000-00003"},{"key":"i0033-7587-166-1-128-b60","doi-asserted-by":"crossref","unstructured":"Dunning Jr., D. E. and G. Schwarz. Variability of human thyroid characteristics and estimates of dose from ingested131I. Health Phys 40:661\u2013675.1981.","DOI":"10.1097\/00004032-198105000-00005"},{"key":"i0033-7587-166-1-128-b63","doi-asserted-by":"crossref","unstructured":"Krohn, K., S. Wohlgemuth, H. Gerber, and R. Paschke. Hot microscopic areas of iodine-deficient euthyroid goiters contain constitutively activating TSH receptor mutations. J. Pathol 192:37\u201342.(2000.","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH650>3.0.CO;2-3"},{"key":"i0033-7587-166-1-128-b64","doi-asserted-by":"crossref","unstructured":"Studer, H., H. J. Peter, and H. Gerber. Natural heterogeneity of thyroid cells: The basis for understanding thyroid function and nodular goiter growth. Endocr. Rev 10:125\u2013135.1989.","DOI":"10.1210\/edrv-10-2-125"},{"key":"i0033-7587-166-1-128-b65","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji129"},{"key":"i0033-7587-166-1-128-b66","doi-asserted-by":"crossref","unstructured":"Boice, J. D. Radiation induced thyroid cancer\u2014What's new? J. Natl. Cancer Inst 97:703\u2013705.2005.","DOI":"10.1093\/jnci\/dji151"},{"key":"i0033-7587-166-1-128-b67","doi-asserted-by":"crossref","unstructured":"Saenger, E. L., G. E. Thoma, and E. A. Tompkins. Incidence of leukemia following treatment of hyperthyroidism: Preliminary report of the cooperative thyrotoxicosis therapy follow-up study. J. Am. Med. Assoc 205:855\u2013862.1968.","DOI":"10.1001\/jama.205.12.855"},{"key":"i0033-7587-166-1-128-b69","doi-asserted-by":"crossref","unstructured":"Dobyns, B. M., G. E. Sheline, J. B. Workman, E. A. Tompkins, W. M. McConahey, and D. V. Becker. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the cooperative thyrotoxicosis therapy follow-up study. J. Clin. Endocrinol. Metab 38:976\u2013998.1974.","DOI":"10.1210\/jcem-38-6-976"},{"key":"i0033-7587-166-1-128-b70","doi-asserted-by":"crossref","unstructured":"Ron, E., M. M. Doody, D. V. Becker, A. B. Brill, R. E. Curtis, M. B. Goldman, B. S H. Harris, D. A. Hoffman, W. M. McConahey, and J. D. Boice. Cancer mortality following treatment for adult hyperthyroidism. J. Am. Med. Assoc 280:347\u2013355.1998.","DOI":"10.1001\/jama.280.4.347"},{"key":"i0033-7587-166-1-128-b71","doi-asserted-by":"crossref","unstructured":"Franklyn, J. A., P. Maisonneuve, M. C. Sheppard, J. Betteridge, and P. Boyle. Mortality after the treatment of hyperthyroidism with radioactive iodine. New Engl. J. Med 338:712\u2013718.1998.","DOI":"10.1056\/NEJM199803123381103"},{"key":"i0033-7587-166-1-128-b72","doi-asserted-by":"crossref","unstructured":"Holm, L. E., P. Hall, K. Wiklund, G. Lundell, G. Berg, G. Bjelkengren, E. Cederquist, U. B. Ericsson, A. Hallquist, and L. G. Larsson. Cancer risk after iodine-131 therapy for hyperthyroidism. J. Natl. Cancer Inst 83:1072\u20131077.1991.","DOI":"10.1093\/jnci\/83.15.1072"},{"key":"i0033-7587-166-1-128-b73","doi-asserted-by":"crossref","unstructured":"Hall, P., G. Berg, G. Bjelkengren, J. D. Boice Jr., U. B. Ericsson, A. Hallquist, M. Lindberg, G. Lundell, J. Tennvall, and L. E. Holm. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int. J. Cancer 50:886\u2013890.1992.","DOI":"10.1002\/ijc.2910500611"},{"key":"i0033-7587-166-1-128-b74","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11258"},{"key":"i0033-7587-166-1-128-b75","doi-asserted-by":"crossref","unstructured":"Hahn, K., P. Schnell-Inderst, B. Grosche, and L. E. Holm. Thyroid cancer after diagnostic administration of iodine-131 in childhood. Radiat. Res 156:61\u201370.2001.","DOI":"10.1667\/0033-7587(2001)156[0061:TCADAO]2.0.CO;2"},{"key":"i0033-7587-166-1-128-b76","doi-asserted-by":"crossref","unstructured":"Holm, L-E., K. E. Wiklund, G. E. Lundell, N. A. Bergman, G. Bjelkengren, E. S. Cederquist, U. B. Ericsson, L. G. Larsson, M. E. Lidberg, and R. S. Lindberg. Thyroid cancer after diagnostic doses of iodine-131: A retrospective cohort study. J. Natl. Cancer Inst 80:1132\u20131138.1988.","DOI":"10.1093\/jnci\/80.14.1132"},{"key":"i0033-7587-166-1-128-b78","doi-asserted-by":"crossref","unstructured":"Edmonds, C. J. and T. Smith. The long term hazards of treatment of thyroid cancer with radioiodine. Br. J. Radiol 59:45\u201357.1986.","DOI":"10.1259\/0007-1285-59-697-45"},{"key":"i0033-7587-166-1-128-b79","doi-asserted-by":"crossref","unstructured":"Brincker, H., H. S. Hansen, and A. P. Anderson. Induction of leukemia by I-131 treatment of thyroid cancer. Br. J. Cancer 28:232\u2013237.1973.","DOI":"10.1038\/bjc.1973.142"},{"key":"i0033-7587-166-1-128-b80","doi-asserted-by":"crossref","unstructured":"Rubino, C., F. de Vathaire, M. E. Dottorini, P. Hall, C. Schvartz, J. E. Couette, M. G. Dondon, M. T. Abbas, C. Langlois, and M. Schlumberger. Second primary malignancies in thyroid cancer patients. Br. J. Cancer 89:1638\u20131694.2003.","DOI":"10.1038\/sj.bjc.6601319"},{"key":"i0033-7587-166-1-128-b81","unstructured":"Sarkar, S. D., W. H. Beierwaltes, S. P. Gill, and B. J. Cowley. Subsequent fertility and birth histories of children and adolescents treated with131I for thyroid cancer. J. Nucl. Med 17:460\u2013464.1976."},{"key":"i0033-7587-166-1-128-b82","doi-asserted-by":"crossref","unstructured":"Handelsman, D. J. and J. R. Turtle. Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer. Clin. Endocrinol 18:465\u2013472.1983.","DOI":"10.1111\/j.1365-2265.1983.tb02876.x"},{"key":"i0033-7587-166-1-128-b83","unstructured":"Loevinger, R. and M. Berman. MIRD Pamphlet No. 1-A: Schema for absorbed-dose calculations for biologically distributed radionuclides. J. Nucl. Med 9:Suppl. 1. 7\u201314.1968."},{"key":"i0033-7587-166-1-128-b85","unstructured":"Coffey, J., M. Cristy, and G. Warner. MIRD Pamphlet No. 13: Specific absorbed fractions for photon sources uniformly distributed in the heart chambers and heart wall of a heterogeneous phantom. J. Nucl. Med 22:65\u201371.1981."},{"key":"i0033-7587-166-1-128-b86","unstructured":"Thomas, S., M. Stabin, C-T. Chen, and R. C. Samaratunga. MIRD Pamphlet No. 14, revised: A dynamic urinary bladder model for radiation dose calculations. J. Nucl. Med 40:Suppl. 783\u2013803.1992."},{"key":"i0033-7587-166-1-128-b87","unstructured":"Thomas, S. R., M. G. Stabin, C. T. Chen, and R. C. Samaratunga. MIRD Pamphlet No. 14, revised: A dynamic urinary bladder model for radiation dose calculations. J. Nucl. Med 40:Suppl. 102S\u2013123S.1999."},{"key":"i0033-7587-166-1-128-b88","unstructured":"Bouchet, L., W. Bolch, D. Weber, H. L. Atkins, and J. Poston Sr. MIRD Pamphlet No. 15: Radionuclide S values in a revised dosimetric model of the adult head and brain. J. Nucl. Med 40:Suppl. 62S\u2013101S.1999."},{"key":"i0033-7587-166-1-128-b89","unstructured":"Siegel, J. A., S. R. Thomas, J. B. Stubbs, M. G. Stabin, M. T. Hays, K. F. Koral, J. S. Robertson, R. W. Howell, B. W. Wessels, and A. B. Brill. MIRD Pamphlet No. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J. Nucl. Med 40:Suppl. 37S\u201361S.1999."},{"key":"i0033-7587-166-1-128-b90","unstructured":"Bolch, W. E., L. G. Bouchet, J. S. Robertson, B. W. Wessels, J. A. Siegel, R. W. Howell, A. K. Erdi, B. Aydogan, S. Costes, and E. E. Watson. MIRD Pamphlet No. 17: The dosimetry of nonuniform activity distributions. Radionuclide S values at the voxel level. J. Nucl. Med 40:Suppl. 11S\u201336S.1999."},{"key":"i0033-7587-166-1-128-b91","unstructured":"Bouchet, L. G., W. E. Bolch, H. P. Blanco, B. W. Wessels, J. A. Siegel, D. A. Rajon, I. Clairand, and G. Sgouros. MIRD Pamphlet No. 19: Absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. J. Nucl. Med 44:1113\u20131147.2003."},{"key":"i0033-7587-166-1-128-b92","unstructured":"Lathrop, K. A., R. E. Johnston, M. Blau, E. O. Rothschild, and E. M. Smith. MIRD dose estimate report no. 1: Selenium-75-l-selenomethionine. J. Nucl. Med 14:49\u201350.1973."},{"key":"i0033-7587-166-1-128-b93","unstructured":"Cloutier, R. J., E. E. Watson, R. L. Hayes, B. Nelson, and E. M. Smith. MIRD dose estimate report no. 2: Summary of current radiation dose estimates to humans from66Ga-68Ga- and72Ga-citrate. J. Nucl. Med 14:755\u2013756.1973."},{"key":"i0033-7587-166-1-128-b94","unstructured":"Atkins, H. L., R. J. Cloutier, K. A. Lathrop, L. M. Freeman, J. G. McAfee, W. B. Nelp, D. D. Patton, and E. M. Smith. MIRD dose estimate report no. 3: Technetium-99m-sulfur colloid in various liver conditions. J. Nucl. Med 16:108. 1975."},{"key":"i0033-7587-166-1-128-b95","unstructured":"Cloutier, R. J., L. M. Freeman, J. G. McAfee, K. R. McCormack, D. D. Patton, L. Rosenthall, and E. M. Smith. MIRD dose estimate report no. 4: Au-198-colloidal gold in various liver conditions. J. Nucl. Med 16:173\u2013174.1975."},{"key":"i0033-7587-166-1-128-b96","unstructured":"Berman, M., L. E. Braverman, J. Burke, L. De Groot, K. R. McCormack, T. H. Oddie, R. H. Rohrer, H. N. Wellman, and E. M. Smith. MIRD dose estimate report no. 5: I-123, I-124, I-125, I-126, I-130, I-131 and I-132 as sodium iodide. J. Nucl. Med 16:857\u2013860.1975."},{"key":"i0033-7587-166-1-128-b97","unstructured":"Blau, M., J. G. McAfee, R. H. Rohrer, W. S. Snyder, and E. M. Smith. MIRD dose estimate report no. 6: Hg-197- and Hg-203-labeled chromerodrin. J. Nucl. Med 16:1095\u20131098.1975."},{"key":"i0033-7587-166-1-128-b98","unstructured":"Freeman, L. M., D. D. Patton, L. Rosenthall, G. V. Taplin, and E. M. Smith. MIRD dose estimate report no. 7: Summary of current radiation dose estimates to humans from I-123, I-124, I-126, I-130, and I-131 as sodium Rose Bengal. J. Nucl. Med 16:1214\u20131217.(1975."},{"key":"i0033-7587-166-1-128-b99","unstructured":"Lathrop, K. E., H. L. Atkins, M. Berman, M. T. Hays, and E. M. Smith. MIRD dose estimate report no. 8: Summary of current radiation dose estimates to normal humans from 99mTc as sodium. J. Nucl. Med 17:74\u201377.1976."},{"key":"i0033-7587-166-1-128-b100","unstructured":"Atkins, H. L., J. S. Robertson, B. Y. Croft, B. Tsui, H. Susskind, K. J. Ellis, M. K. Loken, and S. Treves. MIRD dose estimate report no. 9: Radioxenons in lung imaging. J. Nucl. Med 21:459\u2013465.(1980."},{"key":"i0033-7587-166-1-128-b101","unstructured":"Blau, M., R. Wicks, S. R. Thomas, and K. A. Lathrop. MIRD dose estimate report no. 10: Albumin microspheres labeled with Tc-99m. J. Nucl. Med 23:915\u2013917.1982."},{"key":"i0033-7587-166-1-128-b102","unstructured":"Robertson, J. S., R. R. Price, T. F. Budinger, V. F. Fairbanks, and M. Pollycove. MIRD dose estimate report no.11: Fe-52, Fe-55, and Fe-59 used to study ferrokinetics. J. Nucl. Med 24:339\u2013348.1983."},{"key":"i0033-7587-166-1-128-b103","unstructured":"Thomas, S. R., H. L. Atkins, J. G. McAfee, M. D. Blaufox, M. Fernandez, P. T. Kirchner, and R. C. Reba. MIRD dose estimate report no. 12: Tc-99m diethylenetriaminepentaacetic acid. J. Nucl. Med 25:503\u2013505.1984."},{"key":"i0033-7587-166-1-128-b104","unstructured":"Weber, D. A., P. T. Makler Jr., E. E. Watson, J. L. Coffey, S. R. Thomas, and J. London. MIRD dose estimate report no. 13: Radiation absorbed dose from technetium-99m-labeled bone imaging agents. J. Nucl. Med 30:1117\u20131122.1989."},{"key":"i0033-7587-166-1-128-b105","unstructured":"Atkins, H. L., S. R. Thomas, U. Buddemeyer, and L. R. Chervu. MIRD dose estimate report no. 14: Radiation absorbed dose from technetium-99m-labeled red blood cells. J. Nucl. Med 31:378\u2013380.1990."},{"key":"i0033-7587-166-1-128-b106","unstructured":"Robertson, J. S., M. D. Ezekowitz, M. K. Dewanjee, M. G. Lotter, and E. E. Watson. MIRD dose estimate report no. 15: Radiation absorbed dose estimates for radioindium-labeled autologous platelets. J. Nucl. Med 33:777\u2013780.1992."},{"key":"i0033-7587-166-1-128-b107","unstructured":"Atkins, H. L., D. A. Weber, H. Susskind, and S. R. Thomas. MIRD dose estimate report no. 16: Radiation absorbed dose from technetium-99m diethyletriaminepentaacetic acid aerosol. J. Nucl. Med 33:1717\u20131719.1992."},{"key":"i0033-7587-166-1-128-b108","unstructured":"Atkins, H. L., J. S. Robertson, and G. Akabani. MIRD dose estimate report no. 17: Radiation absorbed dose estimates from inhaled krypton-81m gas in lung imaging. J. Nucl. Med 34:1382\u20131384.1993."},{"key":"i0033-7587-166-1-128-b109","unstructured":"Mardirossian, G., A. B. Brill, S. J. Harwood, J. Olsen, K. A. Dwyer, and J. A. Siegel. MIRD dose estimate report no. 18: Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer. J. Nucl. Med 39:671\u2013676.1998."}],"container-title":["Radiation Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T22:42:13Z","timestamp":1555713733000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bioone.org\/doi\/10.1667\/RR3558.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1667\/RR3558.1"],"URL":"https:\/\/doi.org\/10.1667\/rr3558.1","relation":{},"ISSN":["0033-7587","1938-5404"],"issn-type":[{"value":"0033-7587","type":"print"},{"value":"1938-5404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}